FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080828049> ?p ?o ?g. }

• W2080828049 endingPage "1550" @default.
• W2080828049 startingPage "1544" @default.
• W2080828049 abstract "The antileukaemic enzyme L-asparaginase is used to achieve the greatest possible reduction in blood levels of the amino acid asparagine, an essential factor for the growth of leukaemic blasts. There are two main sources of the enzyme, E. coli and Erwinia. Faced with increasing reports of treatment complications, we established a programme to monitor enzyme activity and asparagine levels in serum, in children receiving treatment for acute lymphoblastic leukaemia (ALL) and non-Hodgkin's lymphoma (NHL). Trough asparagine and asparaginase levels were measured in 49 children on induction treatment with different E. coli preparations (Asparaginase medac, Crasnitin) and in 52 children on re-induction (Asparaginase medac, Crasnitin, and, in the event of allergic reactions, Erwinase) just prior to each sequential application of 10000 U/m2 of asparaginase. Measurements were made by an enzyme assay and an HPLC method. During induction, both Escherichia coli preparations induced the desired reduction in asparagine, but the asparaginase activity with Asparaginase medac was significantly higher than with Crasnitin (median of trough levels 475 versus 74 U/l). Under re-induction treatment (median, Asparaginase medac 528 U/l, Crasnitin 49 U/l, and Erwinase < 20 U/l) complete asparagine depletion was recorded on day 3 in more than 90% of Asparaginase medac samples, more than 60% of Crasnitin samples and in 26% of Erwinase samples. The latter two groups included some children with unchanged asparagine levels and no measurable enzyme activity. Different asparaginase preparations are not readily interchangeable. When Asparaginase medac is used instead of Crasnitin, and identical dose will be associated with significantly higher enzyme activity, well above the level required for complete asparagine depletion. Clinical studies will need to specify both the preparation and the dose to be used. When substitution of an alternative drug is mandatory owing to allergic reactions, monitoring is advisable." @default.
• W2080828049 created "2016-06-24" @default.
• W2080828049 creator A5004681014 @default.
• W2080828049 creator A5024352610 @default.
• W2080828049 creator A5028506380 @default.
• W2080828049 creator A5031643099 @default.
• W2080828049 creator A5034614080 @default.
• W2080828049 creator A5044138253 @default.
• W2080828049 creator A5060098976 @default.
• W2080828049 creator A5063810146 @default.
• W2080828049 creator A5080508112 @default.
• W2080828049 date "1996-08-01" @default.
• W2080828049 modified "2023-10-16" @default.
• W2080828049 title "Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations" @default.
• W2080828049 cites W1852365161 @default.
• W2080828049 cites W1940732706 @default.
• W2080828049 cites W1982935511 @default.
• W2080828049 cites W1987590182 @default.
• W2080828049 cites W1990294422 @default.
• W2080828049 cites W2005733409 @default.
• W2080828049 cites W2009387839 @default.
• W2080828049 cites W2010064279 @default.
• W2080828049 cites W2014405408 @default.
• W2080828049 cites W2018573935 @default.
• W2080828049 cites W2028579560 @default.
• W2080828049 cites W2044970079 @default.
• W2080828049 cites W2062338304 @default.
• W2080828049 cites W2067667576 @default.
• W2080828049 cites W2071118209 @default.
• W2080828049 cites W2074110119 @default.
• W2080828049 cites W2075753641 @default.
• W2080828049 cites W2081093059 @default.
• W2080828049 cites W2131210070 @default.
• W2080828049 cites W2222652101 @default.
• W2080828049 cites W229376883 @default.
• W2080828049 doi "https://doi.org/10.1016/0959-8049(96)00131-1" @default.
• W2080828049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8911116" @default.
• W2080828049 hasPublicationYear "1996" @default.
• W2080828049 type Work @default.
• W2080828049 sameAs 2080828049 @default.
• W2080828049 citedByCount "186" @default.
• W2080828049 countsByYear W20808280492012 @default.
• W2080828049 countsByYear W20808280492013 @default.
• W2080828049 countsByYear W20808280492014 @default.
• W2080828049 countsByYear W20808280492015 @default.
• W2080828049 countsByYear W20808280492016 @default.
• W2080828049 countsByYear W20808280492017 @default.
• W2080828049 countsByYear W20808280492018 @default.
• W2080828049 countsByYear W20808280492019 @default.
• W2080828049 countsByYear W20808280492020 @default.
• W2080828049 countsByYear W20808280492021 @default.
• W2080828049 countsByYear W20808280492022 @default.
• W2080828049 countsByYear W20808280492023 @default.
• W2080828049 crossrefType "journal-article" @default.
• W2080828049 hasAuthorship W2080828049A5004681014 @default.
• W2080828049 hasAuthorship W2080828049A5024352610 @default.
• W2080828049 hasAuthorship W2080828049A5028506380 @default.
• W2080828049 hasAuthorship W2080828049A5031643099 @default.
• W2080828049 hasAuthorship W2080828049A5034614080 @default.
• W2080828049 hasAuthorship W2080828049A5044138253 @default.
• W2080828049 hasAuthorship W2080828049A5060098976 @default.
• W2080828049 hasAuthorship W2080828049A5063810146 @default.
• W2080828049 hasAuthorship W2080828049A5080508112 @default.
• W2080828049 hasConcept C126322002 @default.
• W2080828049 hasConcept C181199279 @default.
• W2080828049 hasConcept C185592680 @default.
• W2080828049 hasConcept C2775895851 @default.
• W2080828049 hasConcept C2778461978 @default.
• W2080828049 hasConcept C2778904437 @default.
• W2080828049 hasConcept C28212737 @default.
• W2080828049 hasConcept C2909962599 @default.
• W2080828049 hasConcept C55493867 @default.
• W2080828049 hasConcept C71924100 @default.
• W2080828049 hasConceptScore W2080828049C126322002 @default.
• W2080828049 hasConceptScore W2080828049C181199279 @default.
• W2080828049 hasConceptScore W2080828049C185592680 @default.
• W2080828049 hasConceptScore W2080828049C2775895851 @default.
• W2080828049 hasConceptScore W2080828049C2778461978 @default.
• W2080828049 hasConceptScore W2080828049C2778904437 @default.
• W2080828049 hasConceptScore W2080828049C28212737 @default.
• W2080828049 hasConceptScore W2080828049C2909962599 @default.
• W2080828049 hasConceptScore W2080828049C55493867 @default.
• W2080828049 hasConceptScore W2080828049C71924100 @default.
• W2080828049 hasIssue "9" @default.
• W2080828049 hasLocation W20808280491 @default.
• W2080828049 hasLocation W20808280492 @default.
• W2080828049 hasOpenAccess W2080828049 @default.
• W2080828049 hasPrimaryLocation W20808280491 @default.
• W2080828049 hasRelatedWork W183374419 @default.
• W2080828049 hasRelatedWork W2028670203 @default.
• W2080828049 hasRelatedWork W2045631642 @default.
• W2080828049 hasRelatedWork W2184928701 @default.
• W2080828049 hasRelatedWork W2187205030 @default.
• W2080828049 hasRelatedWork W2599906910 @default.
• W2080828049 hasRelatedWork W2898723676 @default.
• W2080828049 hasRelatedWork W3026662494 @default.
• W2080828049 hasRelatedWork W2310647452 @default.
• W2080828049 hasRelatedWork W84278585 @default.

• next